Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals

13th November 2025 Uncategorised 0

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies to provide direct access to their popular obesity meds.

More: Lilly, Novo shoot down claims of DTC obesity drug partnership with Mangoceuticals
Source: fierce